Bank of Montreal
MRTX

Bank of Montreal’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bank of Montreal’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-651,314
Closed -$38.4M – 4490
2023
Q4 		$38.4M Buy
+651,314
New +$36.6M 0.01% 565
2022
Q3 		– Sell
-598,362
Closed -$41.3K – 4504
2022
Q2 		$41.3K Buy
598,362
+398,480
+199% +$25.3M 0.02% 483
2022
Q1 		$17.1M Buy
+199,882
New +$20.4M 0.01% 892
2021
Q4 		– Sell
-7,753
Closed -$1.35M – 3965
2021
Q3 		$1.35M Sell
7,753
-85,252
-92% -$13.7M ﹤0.01% 2303
2021
Q2 		$15.2M Buy
93,005
+90,680
+3,900% +$14.6M 0.01% 1044
2021
Q1 		$388K Sell
2,325
-4,724
-67% -$935K ﹤0.01% 2792
2020
Q4 		$1.48M Sell
7,049
-4,859
-41% -$1.05M ﹤0.01% 1993
2020
Q3 		$2.04M Buy
11,908
+5,752
+93% +$787K ﹤0.01% 1654
2020
Q2 		$713K Sell
6,156
-26,585
-81% -$2.58M ﹤0.01% 2093
2020
Q1 		$2.47M Buy
32,741
+12,125
+59% +$1.09M ﹤0.01% 1332
2019
Q4 		$2.66M Sell
20,616
-2,994
-13% -$289K ﹤0.01% 1716
2019
Q3 		$1.84M Buy
23,610
+21,294
+919% +$2M ﹤0.01% 1742
2019
Q2 		$239K Buy
+2,316
New +$180K ﹤0.01% 2828
2019
Q1 		– Sell
-285
Closed -$12K – 4854
2018
Q4 		$12K Buy
285
+146
+105% +$5.82K ﹤0.01% 3845
2018
Q3 		$7K Buy
139
+10
+8% +$557 ﹤0.01% 4046
2018
Q2 		$6K Buy
+129
New +$4.87K ﹤0.01% 4099

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of Montreal's MRTX Position: Q1 2024 in Review

Bank of Montreal sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 651,314 shares — an estimated $38.4M sold.

Bank of Montreal first reported a position in MRTX in Q2 2018 and held it in 16 quarters. The position peaked at $38.4M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Bank of Montreal reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 651,314 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $38.4M.
  • Bank of Montreal first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2018 and held it in 16 quarters.
  • Bank of Montreal's Mirati Therapeutics, Inc. Common Stock position peaked at $38.4M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.